Author

Rozenn Brillet

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Abdelhakim Ahmed‐BelkacemiD· 1 shared Alexandre BancetiD· 1 shared Angélique MularoniiD· 1 shared Bryan Jimenez-ArayaiD· 1 shared D. Grenier· 1 shared Dennis Salomon Lopez MolinaiD· 1 shared Isabelle KrimmiD· 1 shared Jean‐Guy DelcrosiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abdelhakim Ahmed‐BelkacemORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses

Dennis Salomon Lopez Molina, Nazim Ahnou, Rozenn Brillet, Jean‐Guy Delcros, Laurent Softic, Bryan Jimenez-Araya, Maxime Duval, Patrice Bruscella, Mario Veruete, Alexandre Bancet, D. Grenier, Angélique Mularoni, Jean–Michel Pawlotsky, Isabelle Krimm, Abdelhakim Ahmed‐Belkacem

This study identifies CK2 as a critical host factor for SARS-CoV-2 replication and shows that the bivalent inhibitor AB668 effectively inhibits multiple coronaviruses.

bioRxiv · Oct 5, 2026 · PreprintMicrobiology